Decoding Bio

Data, companies, and ideas from the frontier of biology.

Your weekly dose of biotech. Read by teams at MIT, Stanford, Harvard, Roche, and more.

KdT is the standard in early-stage science-driven venture capital. We help founders and their companies re-architect the world at a molecular level.